About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

Treatment Strategies for Patients with Acute Carotid Syndromes

Citation:

US Cardiology 2009;6(2):84–6

Prevention of Cardiovascular Risk in Diabetic Patients - An Update

Citation:

European Cardiology Review 2007;2(2):27–9

The Effects of Plant Stanol Ester in Different Subject Groups

Citation:

European Cardiology 2010;6(3):18–21

Characteristics of Adiponectin and Coronary Plaque - An Intravascular Ultrasound Study

Citation:

Interventional Cardiology 2008;3(1):30-2